There have been a series of studies, somewhere in the region of 60, relating increased levels of IGF-1 and breast, colon and prostate cancers.
Proveden je niz studija, negdje oko 60, koji povezuju povišen nivo IGF-1 s rakom dojke, debelog crijeva i prostate.